| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 1082-57-1 | 曲馬唑啉; 2-(5,6,7,8-四氫-1-萘氨基)-2-咪唑啉 | Tramazoline; 2-(5,6,7,8-Tetrahydro-1-naphthylamino)-2-imidazoline; 4,5-Dihydro-N-(5,6,7,8-tetrahydro-1-naphthalenyl)-1H-imidazol-2-amine |  | C13H17N3 | 詳情 | 供應商 |
| 4418-61-5 | 5-氨基四氮唑 | 5-Aminotetrazole; 1H-Tetrazol-5-amine; 5-Amino-1H-tetrazole; Tetrazol-5-ylamine |  | CH3N5 | 詳情 | 供應商 |
| 6154-04-7 | 2-甲基-5-氨基-2H-四氮唑 | 5-Amino-2-methyl-2H-tetrazole; 2H-Tetrazole,5-amino-2-methyl- (6CI,7CI,8CI); (2-Methyl-2H-tetrazol-5-yl)amine; 2-Methyl-2H-tetrazol-5-amine; 2-Methyl-5-aminotetrazole; 2-Methyl-5-tetrazolamine; 5-Amino-2-methyl-2H-tetrazole; 5-Amino-2-methyltetrazole; NSC 141015 |  | C2H5N5 | 詳情 | 供應商 |
| 24209-38-9 | 7-氨基-3-(1-甲基-1H-四唑-5-硫代甲基)-8-氧代-5-硫雜-1-氮雜雙環(huán)[4.2.0]辛-2-烯-2-羧酸 | 7-Amino-3-(1-methyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid; 7-TMCA |  | C10H12N6O3S2 | 詳情 | 供應商 |
| 25953-19-9 | 頭孢唑啉; 唑啉頭孢菌素; (6R,7R)-3-[(5-甲基-1,3,4-噻二唑-2-基)硫甲基]-8-氧代-7-[[2-(四唑-1-基)乙酰]氨基 | Cefazolin; (6R,7R)-3-[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |  | C14H14N8O4S3 | 詳情 | 供應商 |
| 26973-24-0 | 頭孢替唑; (6R,7R)-3-[(1,3,4-噻二唑-2-基)硫代甲基]-8-氧代-7-[2-(1H-四唑-1-基)乙酰氨基]-5-硫雜-1-氮雜雙 | Ceftezole; (6R,7R)-8-Oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-3-[(1,3,4-thiadiazol-2-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |  | C13H12N8O4S3 | 詳情 | 供應商 |
| 27164-46-1 | 頭孢唑啉鈉; (6R,7R)-3-[[(5-甲基-1,3,4-噻二唑-2-基)硫]甲基]-7-[(1H-四唑-1-基)乙酰氨基]-8-氧代-5-硫雜-1 | Cefazolin sodium salt; Sodium (6R-trans)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |  | C14H13N8NaO4S3 | 詳情 | 供應商 |
| 27589-33-9 | 阿佐酰胺; 2-氯-5-(1H-四氮唑-5-基)-4-(2-噻吩甲基氨基)苯磺酰胺 | Azosemide; 2-Chloro-5-(1H-tetrazol-5-yl)-4-(2-thenylamino)benzenesulphonamide |  | C12H11ClN6O2S2 | 詳情 | 供應商 |
| 30034-03-8 | 頭孢孟多鈉; 頭孢孟多酯鈉; (6R,7R)-3-[[(1-甲基-1H-四唑-5-基)硫]甲基]-7-[(R)-2-羥基-2-苯乙酰氨基]-8-氧代 | Sodium cefamandole; Sodium (6R-(6alpha,7beta(R*)))-7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate |  | C18H17N6NaO5S2 | 詳情 | 供應商 |
| 34444-01-4 | 頭孢孟多; 7-[(2-羥基-2-苯基乙酰)氨基]-3-[(1-甲基四唑-5-基)硫甲基]-8-氧代-5-硫雜-1-氮雜雙環(huán)[4.2.0]辛-2 | Cefamandole; 7-[(2-Hydroxy-2-phenylacetyl)amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |  | C18H18N6O5S2 | 詳情 | 供應商 |
| 41136-22-5 | 頭孢替唑鈉; (6R,7R)-3-[(1,3,4-噻二唑-2-基)硫代甲基]-8-氧代-7-[2-(1H-四唑-1-基)乙酰氨基]-5-硫雜-1-氮雜 | Ceftezole sodium; 8-Oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-3-[(1,3,4-thiadiazol-2-ylthio)methyl]-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monosodium salt |  | C13H11N8NaO4S3 | 詳情 | 供應商 |
| 54636-84-9 | N-[4-氯-3-[[4,5-二氫-5-氧代-1-(2,4,6-三氯苯基)-1H-吡唑-3-基]氨基]苯基]十四烷酰胺 | N-(4-Chloro-3-((4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl)amino)phenyl)myristamide; N-(4-Chloro-3-((4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl)amino)phenyl)tetradecanamide |  | C29H36Cl4N4O2 | 詳情 | 供應商 |
| 56610-72-1 | 7beta-氨基-7alpha-甲氧基-3-(1-甲基-1H-四唑-5-硫甲基)-8-氧代-5-硫-1-雜氮雙環(huán)[4.2.0]辛-2-烯-2-甲酸二苯 | 7-MAC; 7-ACA-3-MTT-7-MO |  | C24H24N6O4S2 | 詳情 | 供應商 |
| 56796-20-4 | 頭孢美唑; (6R-cis)-7-[[[(氰甲基)硫]乙酰]氨基]-7-甲氧基-3-[[(1-甲基-1H-四唑-5-基)硫]甲基]-8-氧代-5-硫? | Cefmetazole; (6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |  | C15H17N7O5S3 | 詳情 | 供應商 |
| 56796-39-5 | 頭孢美唑鈉; (6R,7S)-7-[[2-(氰甲基硫)乙酰]氨基]-7-甲氧基-3-[(1-甲基四唑-5-基)硫甲基]-8-氧代-5-硫雜-1-? | Cefmetazole sodium; Sodium (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |  | C15H16N7NaO5S3 | 詳情 | 供應商 |
| 60925-61-3 | 頭孢雷特; (6R,7R)-7-[[2-[2-(氨基甲基)苯基]乙酰]氨基]-3-[[1-(羧甲基)四唑-5-基]硫甲基]-8-氧代-5-硫雜-1- | Ceforanide; (6R,7R)-7-[[2-[2-(Aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |  | C20H21N7O6S2 | 詳情 | 供應商 |
| 61270-71-1 | (6R-反式)-7-氨基-8-氧代-3-(((1-(磺酸甲基)-1H-四唑-5-基)硫)甲基)-5-硫雜-1-氮雜雙環(huán)[4.2.0]辛-2-烯-2-羧 | (6R-trans)-7-Amino-8-oxo-3-(((1-(sulphomethyl)-1H-tetrazol-5-yl)thio)methyl)-5-thia-1-azabicyclo[4.2; 7-ACA-3-SMT |  | C10H12N6O6S3 | 詳情 | 供應商 |
| 61354-99-2 | N-[4-氯-3-[[4,5-二氫-5-氧代-1-(2,4,6-三氯苯基-1H-吡唑-3-基)氨基]苯基]-2-[3-叔丁基-4-羥基苯氧基]十四? | 2-(3-tert-Butyl-4-hydroxyphenoxy)-N-(4-chloro-3-((4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyr; N-(4-Chloro-3-((4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl)amino)phenyl)-2-(3-(1,1-dimethylethyl)-4-hydroxyphenoxy)-tetradecanamide |  | C39H48Cl4N4O4 | 詳情 | 供應商 |
| 61607-68-9 | 1-(2-二甲基氨基乙基)-1H-5-巰基-四氮唑; 5-巰基-1-二甲氨基-乙基-1H-四氮唑 | 1-[2-(Dimethylamino)ethyl]-1H-tetrazole-5-thiol; 1-[2-(Dimethylamino)ethyl]-1,2-dihydro-5H-tetrazole-5-thione; 1-(2-Dimethylaminoethyl)-5-mercapto-1,2,3,4-tetrazole |  | C5H11N5S | 詳情 | 供應商 |
| 61622-34-2 | 頭孢替安; 7-[[(2-氨基-4-噻唑基)乙酰基]氨基]-3-[[[1-[(2-(二甲氨基)乙基]-1H-四唑-5-基]硫代甲基]-8-氧代- | Cefotiam; 8-[2-(2-Amino-1,3-thiazol-4-yl)acetyl]amino-4-[[1-(2-dimethylaminoethyl)tetrazol-5-yl]sulfanylmethyl]-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid |  | C18H23N9O4S3 | 詳情 | 供應商 |